LOS ANGELES, Feb. 9, 2016 /PRNewswire/ -- Med-X, Inc. (Med-X)
today announced that their Regulation A+ (Reg A+) equity
crowdfunding campaign - one of the first of its kind for the
medical cannabis industry - is now accepting investment funding
beginning at the $420 level or 700
shares. In approximately an 8 week period Med-X was able to receive
$3.6 million in reservations from
over 1100 prospective investors for their Reg A+ campaign on
StartEngine.com.
"This offering presents a tremendous opportunity for American
investors seeking to get in on the ground floor of the burgeoning
cannabis industry -- without the normal accreditation requirements
for start-up companies," said Matthew
Mills, COO of Med-X. "Virtually any American who earns an
annual income of $4,200 and is age 18
or older can participate. Keep in mind that you're not simply
investing in the cannabis industry; you're investing in our green
medicine mission. What's more, the successful launch of Med-X is
100% due to the opportunity brought to us by the JOBS Act of 2012.
We are proof that if you are willing to sacrifice the time and
effort to do it right, following all the rules of crowdfunding and
raising capital is a worthwhile endeavor."
In addition to the success of their equity crowdfunding
campaign, Med-X's flagship product, Nature-Cide All Purpose
Insecticide, has continued to gain a following. This has prompted
Med-X to prepare for the release of their second natural product in
Q3 and Q4 of 2016, a patent-pending proprietary natural soil blend
that encompasses natural insecticidal properties. "Comprised of
100% various natural proven pest-preventing plant matter and
superior cultivation ingredients, this soil gives cultivators one
natural proven brand for all their growing medium and pest
prevention needs for cannabis cultivation," states Mills.
By using the insecticidal soil along with Nature-Cide products,
Med-X has been cultivating and protecting cannabis plants
throughout multiple cultivation cycles in the Med-X Lab. By
providing these all-natural solutions, Med-X is on track to become
the industry leader in integrated pest-management solutions for
cannabis cultivation, thus creating a new standard for organic
medicine.
An In-depth Look at the Cannabis Industry; How Anyone Can
Invest
The $5.4 billion legal
cannabis industry is poised to reach $6.7
billion by 2016 and $21
billion by 2020, according to industry analyst ArcView
Market Research. To learn more about the future of this rapidly
growing industry -- including important innovations in cultivation,
research and development -- and Med-X's current investment
opportunity, visit https://www.startengine.com/startup/med-x.
ABOUT MED-X, INC.
Med-X, Inc. is a Nevada corporation formed in February 2014 to support the fast-paced emerging
cannabis industry through such activities as compound
identification and extraction of the identified cannabidiol (CBD)
compounds for the present medical industry demand. The company's
digital magazine, The Marijuana Times, publishes quality media
content for the medical cannabis community to generate revenue from
advertisers as well as sell industry related merchandise to
consumers. The company is ready to bring various products to market
in the cannabis, agricultural and ancillary services industries
through manufacturing partnerships. For more information regarding
Med-X, Inc., please visit www.medx-rx.com, email
info@medx-rx.com or call 818-349-2870.
DISCLAIMER AND FORWARD-LOOKING STATEMENTS
The
securities offered hereby are highly speculative. Investing in
shares of MED-X, INC. involves significant risks. This investment
is suitable only for persons who can afford to lose their entire
investment. Furthermore, investors must understand that an
investment could be illiquid for an indefinite period of time. No
public market currently exists for the securities and if a public
market develops following this offering it may not continue. You
should read the offering circular before making any investment.
This release may contain forward-looking statements regarding
projected business performance, operating results, financial
condition and other aspects of the company, expressed by such
language as "expected," "anticipated," "projected" and
"forecasted." Please be advised that such statements are estimates
only and there is no assurance that the results stated or implied
by forward-looking statements will actually be realized by the
company. Forward-looking statements may be based on management
assumptions that prove to be wrong. The company and its business
are subject to substantial risks and potential events beyond its
control that would cause material differences between predicted
results and actual results, including the company incurring
operating losses and experiencing unexpected material adverse
events.
Media Contact:
Grant
Harvey
grant@crowdfundx.io
805-698-5122
Photo - http://photos.prnewswire.com/prnh/20160209/331555
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/med-x-inc-announces-live-offering-to-sell-shares-via-equity-crowdfunding-300217779.html
SOURCE Med-X, Inc.